These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1995766)

  • 21. Prolonged interval high-dose intravenous immunoglobulin in patients with primary immunodeficiency states.
    Montanaro A; Pirofsky B
    Am J Med; 1984 Mar; 76(3A):67-72. PubMed ID: 6424459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increase of serum immunoglobulin level into the normal range in primary hypogammaglobulinaemia by dosage individualization of intravenous immunoglobulin.
    Leen CL; Yap PL; McClelland DB
    Vox Sang; 1986; 51(4):278-86. PubMed ID: 3798863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Subcutaneous immunoglobulin substitution and therapy].
    Gulácsy V; Maródi L
    Orv Hetil; 2011 Jan; 152(2):64-7. PubMed ID: 21177233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Self-infusion with immunoglobulin at home.
    Chapel H; Brennan V
    J Clin Pathol; 1991 May; 44(5):358-9. PubMed ID: 2045492
    [No Abstract]   [Full Text] [Related]  

  • 25. Use of a new chemically modified intravenous IgG preparation in severe primary humoral immunodeficiency: clinical efficacy and attempts to individualize dosage.
    Schiff RI; Rudd C; Johnson R; Buckley RH
    Clin Immunol Immunopathol; 1984 Apr; 31(1):13-23. PubMed ID: 6421523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of a novel human intravenous immunoglobulin 10% in patients with primary immunodeficiency diseases: Analysis of a phase III, multicentre, prospective, open-label study.
    Melamed IR; Borte M; Trawnicek L; Kobayashi AL; Kobayashi RH; Knutsen A; Gupta S; Smits W; Pituch-Noworolska A; Strach M; Pulka G; Ochs HD; Moy JN
    Eur J Pharm Sci; 2018 Jun; 118():80-86. PubMed ID: 29522908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia. A randomized, double-blind, multicenter crossover trial.
    Eijkhout HW; van Der Meer JW; Kallenberg CG; Weening RS; van Dissel JT; Sanders LA; Strengers PF; Nienhuis H; Schellekens PT;
    Ann Intern Med; 2001 Aug; 135(3):165-74. PubMed ID: 11487483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunoglobulin treatment for primary antibody deficiencies: advantages of the subcutaneous route.
    Gardulf A
    BioDrugs; 2007; 21(2):105-16. PubMed ID: 17402794
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of various doses of intravenous polyclonal IgG on in vivo levels of 12 pneumococcal antibodies in patients with chronic lymphocytic leukaemia and multiple myeloma.
    Sklenar I; Schiffman G; Jønsson V; Verhoef G; Birgens H; Boogaerts M; Ferrant A; Christensen BE; Hasle H; Drivsholm A
    Oncology; 1993; 50(6):466-77. PubMed ID: 8233289
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experience with Subgam, a Subcutaneously Administered Human Normal Immunoglobulin (ClinicalTrials.gov--NCT02247141).
    Dash C; Gascoigne E; Gillanders K; Gooi H
    PLoS One; 2015; 10(7):e0131565. PubMed ID: 26222441
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of a new 10% intravenous immunoglobulin in patients receiving replacement therapy for primary immunodeficiency.
    Wasserman RL; Church JA; Peter HH; Sleasman JW; Melamed I; Stein MR; Bichler J;
    Eur J Pharm Sci; 2009 Jun; 37(3-4):272-8. PubMed ID: 19491015
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies: safety and costs.
    Gardulf A; Andersen V; Björkander J; Ericson D; Frøland SS; Gustafson R; Hammarström L; Jacobsen MB; Jonsson E; Möller G
    Lancet; 1995 Feb; 345(8946):365-9. PubMed ID: 7845120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunoglobulin subclasses and prophylactic use of immunoglobulin in immunoglobulin G subclass deficiency.
    Söderström T; Söderström R; Enskog A
    Cancer; 1991 Sep; 68(6 Suppl):1426-9. PubMed ID: 1908745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the clinical efficacy and safety of an intramuscular and an intravenous immunoglobulin preparation for replacement therapy in idiopathic adult onset panhypogammaglobulinaemia.
    Garbett ND; Currie DC; Cole PJ
    Clin Exp Immunol; 1989 Apr; 76(1):1-7. PubMed ID: 2500273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Subcutaneous infusion of IgG in patients with hypogammaglobulinemia].
    Effersøe H; Andersen V
    Ugeskr Laeger; 1985 Oct; 147(42):3303-5. PubMed ID: 4082313
    [No Abstract]   [Full Text] [Related]  

  • 36. Self-administered hyaluronidase-facilitated subcutaneous immunoglobulin therapy in complicated primary antibody deficiencies.
    Danieli MG; Pulvirenti F; Rocchi V; Morariu R; Quinti I
    Immunotherapy; 2016 Sep; 8(9):995-1002. PubMed ID: 27485073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Intravenous and subcutaneous immunoglobulin therapy].
    Thon V
    Epidemiol Mikrobiol Imunol; 2013 Jul; 62(2):64-73. PubMed ID: 23964967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Multicentre Study on the Efficacy, Safety and Pharmacokinetics of IqYmune®, a Highly Purified 10% Liquid Intravenous Immunoglobulin, in Patients with Primary Immune Deficiency.
    Krivan G; Chernyshova L; Kostyuchenko L; Lange A; Nyul Z; Derfalvi B; Musial J; Bellon A; Kappler M; Sadoun A; Bernatowska E
    J Clin Immunol; 2017 Aug; 37(6):539-547. PubMed ID: 28711959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune globulin (human) 10 % liquid: a review of its use in primary immunodeficiency disorders.
    McCormack PL
    BioDrugs; 2013 Aug; 27(4):393-400. PubMed ID: 23703447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kinetics of cytomegalovirus IgG antibody following infusion of a hyperimmune globulin preparation in allogeneic marrow transplant recipients.
    Reusser P; Osterwalder B; Gratama JW; The TH; Gratwohl A; Speck B
    Bone Marrow Transplant; 1989 May; 4(3):267-72. PubMed ID: 2543469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.